A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy

NCT04200352 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
44
Enrollment
INDUSTRY
Sponsor class

Stopped Failure of TV50717-CNS-30080 (parent study) to meet the primary efficacy endpoint

Conditions

Interventions

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.